Action - DNA

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Featured Stocks on Today's Edition of The Analyst's Review: DNA, CELG, GILD, ALNY, REGN

An all-new interview with Scott Sand, CEO of Ingen Technologies, Inc. is also available on WallSt.net NEW YORK, Feb. 12 /PRNewswire/ -- The...

Featured Stocks on Today's Edition of The Analyst's Review: DNA, AMGN, BIIB, CELG, MLNM, BMRN

NEW YORK, Jan. 18 /PRNewswire/ -- The Analyst's Review is a daily podcast hosted by WallSt.net editor, Henry Truc that airs every morning at 9...

FDA APPROVES HERCEPTIN(R) (TRASTUZUMAB) FOR THE ADJUVANT TREATMENT OF HER2-POSITIVE NODE-POSITIVE BREAST CANCER

ADDITIONAL RESOURCES: Video, hard copy requests, contact information and more available at: http://www.prnewswire.com/broadcast/23534/consumer.html...

Genentech Receives Complete Response Letter From FDA for Avastin(R) in Metastatic Breast Cancer

SOUTH SAN FRANCISCO, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Genentech, Inc. today announced that it received a Complete Response Letter from...

Genentech Foundation for Biomedical Sciences Awards $1.2 Million to Health Science Education Programs in the Bay Area

SOUTH SAN FRANCISCO, Calif., Aug. 17 /PRNewswire-FirstCall/ -- The Genentech Foundation for Biomedical Sciences announced today that its Board...

MORNING UPDATE: Seven Summits Research Issues Alerts for DNA, PDG, AMT, FDX, and CMVT

CHICAGO, Dec. 7 /PRNewswire/ -- Seven Summits Research issues the following Morning Update at 8:30 AM EST with new PriceWatch Alerts for key...

NFL Stars Play for Non-Hodgkin's Lymphoma Patients

Tiki Barber, Shaun Alexander and Others Join Merril Hoge and Dedicate 2005 Season to Raising Awareness of One of the Fastest Growing Cancers in...

Genentech Foundation for Biomedical Sciences Bolsters Innovation in Health Science Education With $1.2 Million for Bay Area Prog

Genentech Foundation for Biomedical Sciences Bolsters Innovation in Health Science Education With $1.2 Million for Bay Area Programs SOUTH SAN...

Preliminary Phase IIb Study Showed Rituxan Improved Symptoms in Rheumatoid Arthritis Patients Who Failed One or More Disease-Mod

Preliminary Phase IIb Study Showed Rituxan Improved Symptoms in Rheumatoid Arthritis Patients Who Failed One or More Disease-Modifying Anti-Rheumat...

Addendum to Genentech Announces Fourth Quarter and Full Year 2004 Results (FINANCIAL TABLES)

Addendum to Genentech Announces Fourth Quarter and Full Year 2004 Results (FINANCIAL TABLES) SOUTH SAN FRANCISCO, Calif., Jan. 10...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

DNA - Frequently Asked Questions (FAQ)

What is the current share price?

The current share price of is $ 0,00

What is the 1 year trading range for share price?

has traded in the range of $ 0,00 to $ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
KUR.HKure Technologies Inc	$ 0,10 (233,33%)	1 000
BYM.HBaymount Incorporated	$ 0,015 (200,00%)	1 000
OVL.HOlivier Ventures Inc	$ 0,015 (200,00%)	55,1k
AGH.HCanadian Silver Hunter Inc	$ 0,04 (100,00%)	2k
WT.HWangton Capital Corp	$ 0,04 (100,00%)	1,5k
SEVSpectra7 Microsystems Inc	$ 0,025 (-58,33%)	826,85k
PORPortofino Resources Inc	$ 0,005 (-50,00%)	126k
CLMConsolidated Lithium Metals Inc	$ 0,005 (-50,00%)	2k
JHCJinhua Capital Corporation	$ 0,025 (-50,00%)	228k
ECAP.PEndurance Capital Corp	$ 0,025 (-37,50%)	1 000
SPCSPC Nickel Corp	$ 0,025 (66,67%)	2,11M
SLGSan Lorenzo Gold Corp	$ 0,30 (-6,25%)	2,11M
PERPeruvian Metals Corp	$ 0,025 (25,00%)	1,71M
FMNFidelity Minerals Corporation	$ 0,04 (0,00%)	1,64M
BYNBanyan Gold Corp	$ 0,23 (4,55%)	1,59M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Dalradian Resources (DNA)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

DNA Dernières nouvelles

Featured Stocks on Today's Edition of The Analyst's Review: DNA, CELG, GILD, ALNY, REGN

Featured Stocks on Today's Edition of The Analyst's Review: DNA, AMGN, BIIB, CELG, MLNM, BMRN

FDA APPROVES HERCEPTIN(R) (TRASTUZUMAB) FOR THE ADJUVANT TREATMENT OF HER2-POSITIVE NODE-POSITIVE BREAST CANCER

Genentech Receives Complete Response Letter From FDA for Avastin(R) in Metastatic Breast Cancer

Genentech Foundation for Biomedical Sciences Awards $1.2 Million to Health Science Education Programs in the Bay Area

MORNING UPDATE: Seven Summits Research Issues Alerts for DNA, PDG, AMT, FDX, and CMVT

NFL Stars Play for Non-Hodgkin's Lymphoma Patients

Genentech Foundation for Biomedical Sciences Bolsters Innovation in Health Science Education With $1.2 Million for Bay Area Prog

Preliminary Phase IIb Study Showed Rituxan Improved Symptoms in Rheumatoid Arthritis Patients Who Failed One or More Disease-Mod

Addendum to Genentech Announces Fourth Quarter and Full Year 2004 Results (FINANCIAL TABLES)

DNA - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Dalradian Resources (DNA) Cours

Dalradian Resources (DNA)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

DNA Dernières nouvelles

Featured Stocks on Today's Edition of The Analyst's Review: DNA, CELG, GILD, ALNY, REGN

Featured Stocks on Today's Edition of The Analyst's Review: DNA, AMGN, BIIB, CELG, MLNM, BMRN

FDA APPROVES HERCEPTIN(R) (TRASTUZUMAB) FOR THE ADJUVANT TREATMENT OF HER2-POSITIVE NODE-POSITIVE BREAST CANCER

Genentech Receives Complete Response Letter From FDA for Avastin(R) in Metastatic Breast Cancer

Genentech Foundation for Biomedical Sciences Awards $1.2 Million to Health Science Education Programs in the Bay Area

MORNING UPDATE: Seven Summits Research Issues Alerts for DNA, PDG, AMT, FDX, and CMVT

NFL Stars Play for Non-Hodgkin's Lymphoma Patients

Genentech Foundation for Biomedical Sciences Bolsters Innovation in Health Science Education With $1.2 Million for Bay Area Prog

Preliminary Phase IIb Study Showed Rituxan Improved Symptoms in Rheumatoid Arthritis Patients Who Failed One or More Disease-Mod

Addendum to Genentech Announces Fourth Quarter and Full Year 2004 Results (FINANCIAL TABLES)

DNA - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS